FDA
-
-
-
-
-
-
-
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
-
-
-
-
-
-
-
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
-
-
-
-
-
-
-
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
-
-
-
-
-
-
-
Ceribell gets FDA clearance for delirium monitoring device
-
-
-
-
-
-
-
Ceribell Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Ceribell files patent complaints against Natus Medical with trade commission
-
-
-
-
-
-
-
Ceribell (CBLL): FDA Clears Ceribell’s Clarity Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Age
-
332,464 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

